Global Regulatory Partners Secures Approval of DMF of Pharmaceutical-Grade Nitroglycerin in China
PRESS RELEASE Global Regulatory Partners Secures Groundbreaking DMF Approval in China for a New Pharmaceutical – Grade Nitroglycerin Formulation in China Global Regulatory Partners (GRP) is
GRP Global Announces Official Launch of Its Website for the Japan Market
Press Release Global Regulatory Partners Launches GRP-Japan website [Tokyo, Japan] – GRP Global is proud to announce the official launch of its dedicated website for
Transfer of Marketing Authorization for “BAQSIMIⓇ nasal powder 3mg” (emergency hypoglycemia treatment) in Japan
Press Release NOTICE – Sucession of BAQSIMIⓇ Nasal Powder 3mg”in Japan : In April 2023, Eli Lilly and Company (headquartered in Indianapolis USA; hereinafter referred
MARKETING AUTHORIZATION TRANSFER APPROVED FOR BAQSIMI® ON BEHALF OF AMPHASTAR PHARMACEUTICALS, INC. IN MEXICO
Press Release Approval of MAT in Mexico for Baqsimi® : On April 24, 2023, Eli Lilly & Co. (“Lilly”) announced that it has entered into
MARKETING AUTHORIZATION TRANSFER APPROVED FOR REDEVANT ON BEHALF OF KOWA COMPANY, LTD. IN MEXICO
Press Release On August 1, 2024 the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) approved the Marketing Authorization Transfer of REDEVANT® from Eli
GLOBAL REGULATORY PARTNERS MEXICO RECEIVES MARKETING APPROVAL OF JYNNEOS® ( MVA-BN®) , MONKEYPOX VACCINE, ON BEHALF OF BAVARIAN NORDIC IN MEXICO
Press Release On June 17th, 2022, Global Regulatory Partner Inc. through its subsidiary in Mexico submitted to the Comisión Federal para la Protección contra Riesgos